18
Views
6
CrossRef citations to date
0
Altmetric
Original Article

T Cell Responses in EAMG-Susceptible and Non-Susceptible Mouse Strains After Immunization with Overlapping Peptides Encompassing the Extracellular Part of Torpedo Californica Acetylcholine Receptor α Chain. Implication to Role in Myasthenia Gravis of Autoimmune T-Cell Responses Against Receptor Degradation Products

, , &
Pages 79-90 | Received 27 Jan 1997, Accepted 16 Jun 1997, Published online: 07 Jul 2009
 

Abstract

To study the role in myasthenia gravis (MG) of peptides resulting from acetylcholine receptor (AChR) degradation, we examined the ability of AChR peptides to induce T cell responses that are capable of cross-reacting with intact AChR. The studies were carried out in an experimental autoimmune MG (EAMG)-susceptible mouse strain [C57BL/6 (B6)J as well as in two non-susceptible strains [B6.C-H-2bm12 (bm12) and C3H/HeJ. A set of overlapping peptides encompassing the extracellular part (residues 1-210) of the α-chain of Torpedo californica (t) AChR were used, individually or in equimolar mixtures, as immunogens. In B6, immunization with peptides α45-60, α 111-126, α 146-162 and α 182-198 gave T cells that responded in vitro to the correlate immunizing peptide. Only the T cells against the latter three peptides cross-reacted with tAChR. Peptide α 146-162 exhibited the highest in vitro reaction with the immunizing peptide and cross-reaction with tAChR. T cells obtained by immunization of B6 with an equimolar mixture of the peptides responded in vitro to peptides α 111-126, α 146-162 and α 182-198 and cross-reacted very strongly with tAChR. In bml2 and C3H/He, a number of peptides evoked, when used individually as immunogens, strong or moderate T cell responses that recognized in vitro the correlate immunizing peptide but cross-reacted poorly with tAChR. Immunization with the mixture of the peptides gave T cells that recognized several peptides in each strain but

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.